Ameriprise’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.7M Buy
577,125
+35,086
+6% +$1.54M 0.01% 1197
2025
Q4
$20.9M Buy
542,039
+131,965
+32% +$5.03M ﹤0.01% 1386
2025
Q3
$14.5M Buy
410,074
+239,346
+140% +$8.66M ﹤0.01% 1633
2025
Q2
$6.15M Buy
170,728
+148,752
+677% +$4.93M ﹤0.01% 2208
2025
Q1
$684K Sell
21,976
-2,256
-9% -$71.5K ﹤0.01% 3374
2024
Q4
$618K Sell
24,232
-23,786
-50% -$631K ﹤0.01% 3443
2024
Q3
$1.36M Buy
48,018
+3,024
+7% +$83.8K ﹤0.01% 3089
2024
Q2
$1.19M Sell
44,994
-132,364
-75% -$3.67M ﹤0.01% 3088
2024
Q1
$5.39M Buy
177,358
+10,806
+6% +$319K ﹤0.01% 2313
2023
Q4
$4.68M Sell
166,552
-2,271,500
-93% -$62.4M ﹤0.01% 2394
2023
Q3
$66.2M Buy
2,438,052
+229,165
+10% +$6.81M 0.02% 640
2023
Q2
$67.9M Buy
2,208,887
+723,451
+49% +$24.5M 0.02% 635
2023
Q1
$53.5M Buy
1,485,436
+98,288
+7% +$3.64M 0.02% 724
2022
Q4
$54.8M Buy
1,387,148
+12,907
+0.9% +$539K 0.02% 688
2022
Q3
$55.2M Buy
1,374,241
+84,542
+7% +$3.61M 0.02% 663
2022
Q2
$54.2M Sell
1,289,699
-2,418
-0.2% -$99.1K 0.02% 686
2022
Q1
$50.3M Sell
1,292,117
-8,554
-0.7% -$336K 0.01% 810
2021
Q4
$51.8M Buy
1,300,671
+8,410
+0.7% +$327K 0.01% 825
2021
Q3
$46.7M Sell
1,292,261
-59,915
-4% -$2.33M 0.01% 799
2021
Q2
$55.4M Buy
1,352,176
+88,292
+7% +$3.76M 0.02% 749
2021
Q1
$55.2M Buy
1,263,884
+471,201
+59% +$22.3M 0.02% 730
2020
Q4
$39.7M Buy
792,683
+171,965
+28% +$7.3M 0.01% 855
2020
Q3
$26.1M Sell
620,718
-804,652
-56% -$34.5M 0.01% 937
2020
Q2
$69.2M Buy
+1,425,370
New +$70.6M 0.03% 501

Other funds holding RPRX